Personalized cancer vaccines may help some brain cancer patients live longer

Personalized cancer vaccines might make notoriously deadly brain cancers more susceptible to immunotherapy, and prolong survival for some patients, a new study from the Dana-Farber Cancer Institute found. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act…

Source: Endpoints News